 HIGHLANDS RANCH, Colo., Dec. 10, 2020 GLOBE NEWSWIRE -- Vivos Therapeutics, Inc. Vivos , a medical technology company that offers novel and proprietary alternatives for treating mild-to-moderate obstructive sleep apnea, today announced the pricing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of 6.00 per share. The shares of common stock are expected to begin trading on the Nasdaq Capital Market under the ticker symbol VVOS on Friday, December 11, 2020. 